Introduction
The three isoforms of TGFb (TGFb1, -2 and -3) are multifunctional cytokines involved in development, immune function and cell cycle control. Although the three TGFbs activate the same TGFb receptor system, the phenotypes of the TGFb isoform knockouts are nonoverlapping. Tgfb1 À/À mice die either during embryogenesis or from a lymphocyte-mediated inflammatory illness a few weeks after birth (Kulkarni et al., 1993; Shull et al., 1992) . The survival of some Tgfb1 À/À embryos to birth may be due to rescue by other TGFb isoforms, maternally derived TGFb1 and/or other factors (Bonyadi et al., 1997; Letterio et al., 1994; Tang et al., 2003) . Tgfb2 À/À mice die perinatally with defects of several organs, including the heart, skeleton and genitourinary tract (Sanford et al., 1997) , while Tgfb3 À/À mice are reported to have cleft palate and delayed lung development, without embryonic lethality (Kaartinen et al., 1995; Proetzel et al., 1995) . TGFb signaling is thought to play a critical role in vascular development and function due to effects on endothelial cell proliferation and migration, fibronectin synthesis and mural cell differentiation (reviewed in Bohnsack and Hirschi, 2004; Perrella et al., 1998) . This idea is supported by the fact that embryonic lethality in some Tgfb1 À/À mouse embryos is due to failed yolk sac vasculogenesis (Dickson et al., 1995) . In addition, mutations in the TGFb receptors endoglin or ALK1 underlie most cases of the vascular disorder hereditary hemorrhagic telangiectasia (Johnson et al., 1996; McAllister et al., 1994) . Integrins, which are transmembrane cell adhesion proteins composed of one a and one b subunit, can also regulate Hynes, 2007; Serini et al., 2006; Stupack and Cheresh, 2004) . For example, antagonists of integrins avb3 and avb5 block angiogenesis in corneal and chorioallantoic membrane assays (Friedlander et al., 1995) , while mice with null mutations in the b3 and b5 integrin subunit genes have enhanced pathologic angiogenesis (Reynolds et al., 2002) . Mouse embryos lacking a5b1, a fibronectin receptor, die at midgestation with severe mesodermal defects and failure of yolk sac vasculogenesis associated with lack of adhesion between the endodermal and mesodermal layers (Yang et al., 1993) . Mice with a null mutation in the b8 gene (Itgb8 À/À ), which lack the integrin avb8, die from one of two defects in vascular development: failure of normal vasculogenesis in the yolk sac, causing death around embryonic day 10 (E10), or abnormal development of the brain vasculature, beginning at E11.5 and characterized by dilated vessels, endothelial cell hyperplasia and hemorrhage (Zhu et al., 2002) . Mice with a null mutation in the av gene (Itgav
), which lack the avb1, avb3, avb5, avb6 and avb8 integrins, die either from early defects in the placenta or from the same brain vascular pathology seen in Itgb8 À/À embryos (Bader et al., 1998) . Similar brain vascular abnormalities occur when Itgb8 or Itgav is conditionally deleted in neuroepithelial cells (McCarty et al., 2005; Proctor et al., 2005) . There are functional links between integrins and TGFb that may have relevance to vascular biology. Two integrins, avb6 and avb8, affect TGFb activity directly by activating latent forms of TGFb1 and TGFb3 (Annes et al., 2002; Araya et al., 2006; Mu et al., 2002; Munger et al., 1999) . TGFb latency occurs because the cytokine associates noncovalently with its propeptide, which is called latency-associated peptide (LAP), after proteolytic processing of the pro-cytokine (Annes et al., 2003) . TGFb1-LAP and TGFb3-LAP contain an integrin binding motif, arginine-glycine-aspartic acid (RGD). avb6 and avb8 mediate the release of TGFb1 or -3 from their respective LAPs by interacting with the RGD sequence, which either induces a conformational change in LAP, in the case of avb6 (Annes et al., 2004) , or leads to protease action on LAP, in the case of avb8 (Mu et al., 2002) .
We generated mice with a knockin mutation in Tgfb1 that inactivates the integrin binding site in LAP in order to determine the extent to which TGFb1 activity is regulated by RGD-binding integrins (Yang et al., 2007) . These mice (designated Tgfb1 RGE/RGE because the aspartic acid residue in the integrin binding site is changed to glutamic acid) have the same developmental defects as Tgfb1 À/À mice, including failure of yolk sac vasculogenesis in about 50% of Tgfb1 RGE/RGE embryos (Yang et al., 2007) . Thus, RGD-binding integrins play a dominant role in activating TGFb1 during development of the yolk sac vasculature. The similarities among the yolk sac vasculogenesis defects in Tgfb1
, Tgfb1 RGE/RGE and Itgb8 À/À mice suggest that this process depends upon avb8-mediated TGFb1 activation. Because TGFb activation by RGD-binding integrins involves two TGFb isoforms (TGFb1 and TGFb3) and at least two RGD-binding integrins (avb6 and avb8), there may be redundancy in the actions of these molecules. We hypothesized that avb8 activates both TGFb1 and TGFb3 during brain vascular development. The hypothesis is plausible because TGFb1 and TGFb3 are both expressed in developing brain Pelton et al., 1990; Pelton et al., 1991) , and avb8 is expressed in the brain on astrocytes surrounding vessels and, indeed, has been proposed to act as an ''angiogenic switch'' in the brain by activating TGFb (Cambier et al., 2005) . If the hypothesis is correct, mice lacking active TGFb1 and TGFb3 should have abnormal brain vascular development similar to that in avb8-null mice (unless other developmental abnormalities preclude assessment of the brain vasculature).
To test this hypothesis, we characterized mice deficient in integrin-mediated TGFb1 activation (Tgfb1
). The only developmental abnormality in these mice, aside from those already reported in knockouts of single TGFb genes, was abnormal brain vascular morphogenesis similar to that in avb8-null mice. We also noted that, on specific genetic backgrounds, Tgfb3 gene status influences the early embryonic lethality due to Tgfb1 mutation, and conversely Tgfb1 gene status subtly influences the cleft palate phenotype of Tgfb3 À/À mice.
Results

Overview of genetic backgrounds used
We will first describe the genetic backgrounds used in the study and the rationale for the backgrounds used. Tgfb1 +/RGE mice were a mixture of backgrounds (C57BL/6J, 129Sv and Swiss-Webster), as previously reported (Yang et al., 2007 +/À mice were backcrossed two generations to this background and crossed, only $25% of Tgfb1 À/À embryos died before birth, the lowest rate among several genetic backgrounds used in that study (Kallapur et al., 1999) . We reasoned that the BALB/c background might also enhance the survivalto-birth rate for Tgfb1 RGE/RGE ; Tgfb3 À/À embryos. Interestingly, partial backcross to the BALB/c background appeared to improve survival of Tgfb1 RGE/RGE embryos only in the presence of two normal Tgfb3 alleles ( an ICR background, for two reasons. First, we maintained Itgb8 +/À mice on this background, and noted that the embryonic lethality rate of the Itgb8 À/À genotype was nil. In contrast, embryonic lethality among Itgb8 À/À embryos on a mixed C57BL/6J and 129/Sv background was reported to be 65% (Zhu et al., 2002) . If the mechanism of death in Itgb8 (Kaartinen et al., 1995; Proetzel et al., 1995; Zhu et al., 2002) . We collected embryos from timed pregnancies to determine the onset and progression of hemorrhage. Brain hemorrhage was visible in Tgfb1 RGE/RGE ; Tgfb3 À/À embryos as early as E11.5, and was severe by E15.5 ( Fig. 1A and B To determine whether the hemorrhage was due to loss of b8 integrin expression because of reduced TGFb signaling, we measured Itgb8 mRNA expression in the brains of newborn control and Tgfb1 RGE/RGE ; Tgfb3 À/À mice by RT-PCR. Affected mice had normal expression of Itgb8 (Fig. 1E) . Therefore, loss of b8 integrin subunit expression does not explain the phenotype of Tgfb1 RGE/RGE ; Tgfb3 À/À mice.
The abnormal histologic findings in Tgfb1 RGE/RGE ; Tgfb3 À/À embryos were similar to those reported for Itgb8 À/À mice (Zhu et al., 2002) . Findings in E13.5 embryos are shown in Fig. 2 . Characteristic gaps (cavitation) were present in the brain parenchyma. Some vessels (mostly in the diencephalon) had an enlarged, hyperproliferative appearance similar to that of glomeruloid bodies (Dome et al., 2007) . We injected BrdU into pregnant females immediately before recovering E13.5 embryos. Prominent BrdU labeling of vessels was noted, particularly in the most hyperplastic vascular structures (Fig. 2B, arrow) ; however, we were unable to obtain an estimate of the BrdU labeling index, which is reported to be increased in Itgb8 À/À brains (Zhu et al., 2002) .
Similar histologic findings in newborn brains are shown in Fig. 3 (Fig. 3B) . 
2.3.
Embryonic lethality among Tgfb1 RGE/RGE ; Tgfb3 À/À embryos on the mixed background occurs between E8.5 and E12.5
Tgfb1 deficiency causes early embryonic lethality by impairing either pre-implantation development or yolk sac vasculogenesis and/or hematopoiesis (Dickson et al., 1995; Kallapur et al., 1999) . We reported that $50% of Tgfb1 RGE/RGE embryos die at $E10.5 (Yang et al., 2007) (Fig. 4A) . Most Tgfb1 RGE/RGE embryos in this analysis were nonviable by E12.5. Affected embryos often had reduced or absent yolk sac vasculature (Fig. 4A, inset) , as previously described in Tgfb1 À/À and Tgfb1 RGE/RGE embryos.
If some Tgfb1 RGE/RGE ; Tgfb3 À/À embryos die earlier than E8.5, this genotype would be present at lower than expected frequency among the E8.5-12.5 embryos. However, the distribution of Tgfb1 and Tgfb3 genotypes in E8.5-12.5 embryos (viable and nonviable) did not differ significantly from the expected Mendelian frequencies (data not shown).
Tgfb1 influences the cleft palate phenotype of Tgfb3
À/À mice on a partial ICR background
Palate formation involves the initial vertical growth of the palatal shelves, horizontal elevation of the shelves with apposition of the medial edge epithelia (MEE), and, at E14.5, fusion of the shelves in the midline with loss of the MEE and degradation of the basement membrane. Cleft palate in Tgfb3 À/À mice is due to failure of fusion and basement membrane degradation, but the role of TGFb3 in this process is not completely understood (Blavier et others have partial fusion, usually of the anterior secondary palate, and the distribution of the types depends upon genetic background (Cui et al., 2005; Kaartinen et al., 1995; Proetzel et al., 1995) . The partial fusion that occurs in some Tgfb3 À/À mice might indicate partial rescue by other TGFb isoforms, but this has not been tested. TGFb1 and TGFb3 are both expressed in MEE cells during palate fusion, whereas TGFb2 is expressed in mesenchymal cells but not in epithelium in the developing palate (Cui et al., 1998; Fitzpatrick et al., 1990) .
We assessed the degree of secondary palate fusion in Tgfb3 À/À mice on the three genetic backgrounds used in this study. On the mixed and BALB/c backgrounds, Tgfb3 À/À mice had either partial or complete clefts, without an obvious influence of Tgfb1 gene status. However, in mice backcrossed three generations onto the ICR background, we noted a strong interaction between the two genes. All double mutant mice (Tgfb1 RGE/RGE ; Tgfb3 (Kaartinen et al., 1995) . However, we observed no consistent changes in lung morphology in Tgfb1 + ; Tgfb3 À/À or Tgfb1 RGE/RGE ; Tgfb3 À/À mice at E17.5 (Fig. 4C ) or at birth (not shown).
Discussion
In the present study, we generated mice with mutations in both Tgfb1 and Tgfb3, the genes encoding TGFb isoforms that have RGD-containing LAPs and can be activated by the RGDbinding integrins avb6 and avb8. The phenotype of these mice constitutes a test of the hypothesis that avb8-mediated activation of TGFb1 and TGFb3 is involved in the development of the brain vasculature.
In developing mouse brain and in fetal human brain, avb8 is expressed by the neuroepithelium, particularly in glial processes surrounding blood vessels (Cambier et al., 2005; Zhu et al., 2002) . During normal brain development, vessels arising in the pia mater penetrate the neuroepithelium and extend by angiogenesis towards the ventricles (Greenberg and Jin, 2005) . Loss of avb8 alters this process (Zhu et al., 2002) . At E10.5, vessels in Itgb8 À/À brain have not penetrated as far into the neuroepithelium as have those in normal brain. By E11.5-12.5, mutant vessels develop into hyperproliferative glomeruloid masses with associated hemorrhage. Radial glial projections are disorganized and cavitation of brain tissue occurs. Similar disturbances occur when Itgb8 is conditionally deleted in neuroepithelium (Proctor et al., 2005) , and in mice lacking all av integrins (Bader et al., 1998; McCarty et al., 2005) . The mechanism underlying the abnormalities in avb8-null mice has not been elucidated. One conjecture is that avb8 organizes the perivascular extracellular matrix or allows proper localization of glial processes around vessels. Another explanation is that avb8-mediated TGFb activation is critical for vascular development. Supporting this idea, Nishimura and colleagues showed that astrocytes express avb8 and activate TGFb in cell culture in an avb8-dependent manner, and that astrocytes alter the behavior of co-cultured endothelial cells via avb8-mediated TGFb activation (Cambier et al., 2005) .
Genetic evidence to date neither contradicts nor directly supports the avb8-TGFb model of brain vascular development. Mice with homozygous null mutations of genes for TGFb receptors (TGFbRII, ALK1, ALK5 and endoglin) have abnormal vascular development (Larsson et al., 2001; Li et al., 1999; Oh et al., 2000; Oshima et al., 1996) , but the early embryonic lethality in these knockouts precludes assessment of the roles of these receptors in brain vascular development. Mice heterozygous for ALK1 and endoglin null mutations have vascular abnormalities similar to hereditary hemorrhagic telangiectasia, but changes in this disease are distinct from findings in avb8-deficient mice (Bourdeau et al., 1999; Srinivasan et al., 2003) . While TGFb1-null mice have an incompletely penetrant defect in yolk sac vasculogenesis (Dickson et al., 1995) , similar to avb8-null mice (Zhu et al., 2002) , and Tgfb2
À/À mice have edema and bruising (Dunker and , neither of these genotypes is associated with abnormal brain vasculature. Therefore, genetic evidence establishes a role for TGFb signaling in vascular development and maintenance generally, but not in the specific brain abnormalities in avb8-null mice. In this study we tested the hypothesis that avb8 utilizes TGFb1 and TGFb3, the TGFb isoforms activated by avb8, as redundant effectors during vascular development in the brain. To do this we examined mice deficient in integrin-mediated TGFb1 activation (Tgfb1 RGE/RGE ) that also had reduced (Tgfb3 Other labs have shown that embryonic lethality in Tgfb1
embryos is strain-dependent. In a study that compared the effects of multiple genetic backgrounds on Tgfb1 À/À embryonic survival, Doetschman and colleagues reported highest embryonic lethality after one or more backcrosses to the C57BL/6J background, and lowest after two generations of backcrossing to the BALB/c background (Kallapur et al., 1999) . By comparing embryonic lethality in the C57BL/6J strain with either NIH/OlaHsd or 129S2/SvHsd strains, Akhurst and colleagues defined three loci that modify embryonic lethality in Tgfb1 À/À embryos (Tang et al., 2005 (Fitzpatrick et al., 1990) . All the genetic backgrounds used in our study were relatively mixed, however, which is an important caveat to the survival data and cleft palate results. In summary, our data support the idea that avb8 expressed on neuroepithelial cells in the developing brain activates TGFb1 and TGFb3, which act redundantly to facilitate normal vascular morphogenesis, and reveal other subtle examples of redundancy between TGFb1 and TGFb3 in development. Additional experiments with mice lacking both avb6 and avb8 function should provide additional information concerning this potentially doubly redundant system of two integrin activators and two TGFb isoforms.
4.
Experimental procedures
Mice
Itgb8 +/À mice, obtained from L. Reichardt, UCSF, were generated as described (Zhu et al., 2002) and had been backcrossed to the ICR background more than seven generations; ICR mice were from Charles River, Wilmington, MA. Tgfb1 RGE/RGE mice on a mixed C57BL/6J/129SvEvTac/Swiss-Webster background were generated and genotyped as described (Yang et al., 2007) . Tgfb3 À/À mice on a C57BL/6J background (strain name B6.129-
Tgfb3 tm1Doe
/J, generation N12+) and BALB/c mice were obtained from Jackson Laboratories, Bar harbor, ME. Tgfb3 À/À mice were genotyped as described (Taya et al., 1999) 
Histology
Mouse tissues were fixed overnight in 10% formalin and embedded in paraffin. Five micrometers sections were used for hematoxylin and eosin staining and BrdU detection.
PECAM immunohistochemistry
Seven micrometers frozen sections of newborn brain were sequentially incubated with a 1:50 dilution of rat ant-PECAM-1 mAb (MEC 13.3, BD Pharmingen, San Jose, CA), 1:100 biotinylated anti-rat antibody (BA-4001, Vector Laboratories, Burlingame, CA) and 1:200 streptavidin-conjugated horse radish peroxidase (SA-5004, Vector Laboratories) and developed with DAB solution (Vector Laboratories), then counterstained with hematoxylin.
BrdU labeling
BrdU in vivo labeling and detection was with the 5-Bromo-2 0 deoxy-uridine Labeling and Detection Kit II (Roche, Mannheim, Germany). Pregnant females were injected with 10 lmol BrdU per 100 g body weight and sacrificed 1 h later. BrdU incorporation was detected in formalin-fixed embryo tissue using the alkaline phosphatase detection system according to the manufacturer's recommendations, followed by hematoxylin counterstaining.
RT-PCR
Brain tissue from newborn mice (ICR backcross) was isolated, and RNA was extracted with Trizol (Invitrogen, Carlsbad, CA) according to the manufacturer's recommendations and reversetranscribed by standard techniques. PCR was done using primers specific for Itgb8 (GAGAAGTCTCAGTCCAACTG and GATGTCTGGT CTGTCATCAC) and Gapdh (ACCACAGTCCATGCCATCAC and ATGT CGTTGTCCCACCACCT). The PCR protocol was 95°C for 4 min, then 35 cycles of 94°C for 40 s, 56°C for 45 s and 72°C for 1 min, then 72 C for 10 min.
mice. This work was funded by NIH Grant R01 HL063786 (J.S. Munger). 
